Cargando…
Genetics-informed precision treatment formulation in schizophrenia and bipolar disorder
Genetically informed drug development and repurposing is an attractive prospect for improving patient outcomes in psychiatry; however, the effectiveness of these endeavors is confounded by heterogeneity. We propose an approach that links interventions implicated by disorder-associated genetic risk,...
Autores principales: | Reay, William R., Geaghan, Michael P., Atkins, Joshua R., Carr, Vaughan J., Green, Melissa J., Cairns, Murray J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502060/ https://www.ncbi.nlm.nih.gov/pubmed/36055211 http://dx.doi.org/10.1016/j.ajhg.2022.07.011 |
Ejemplares similares
-
Genetic estimates of correlation and causality between blood-based biomarkers and psychiatric disorders
por: Reay, William R., et al.
Publicado: (2022) -
Pharmacological enrichment of polygenic risk for precision medicine in complex disorders
por: Reay, William R., et al.
Publicado: (2020) -
Polygenic disruption of retinoid signalling in schizophrenia and a severe cognitive deficit subtype
por: Reay, William R., et al.
Publicado: (2018) -
The MIR137 VNTR rs58335419 Is Associated With Cognitive
Impairment in Schizophrenia and Altered Cortical Morphology
por: Mahmoudi, Ebrahim, et al.
Publicado: (2020) -
F193. DYSREGULATION OF RETINOID SIGNALLING IN SCHIZOPHRENIA OBSERVED IN WHOLE GENOME SEQUENCE ANALYSIS
por: Reay, William, et al.
Publicado: (2018)